Monday, May 27, 2013

Celtics' Kevin Garnett To Avoid Foot Surgery

According to Steve Bulpett of the Boston Herald, Boston Celtics forward Kevin Garnett will not need
surgery on his left ankle. The Celtics medical staff believes Garnett will heal with time and rest.
Garnett spent the last few months of the regular season and missed several games with a foot/ankle injury (bone spurs). Surgery seemed like it was a high possibility.
President of basketball operations Danny Ainge said, "I think there was some question whether he was going to have surgery on his foot. But the last I heard, which was a few days ago, is that he won't need surgery."
Now that surgery has been ruled out, the Celtics are still unsure if Garnett will be back next season. The Celtics are giving Garnett, 37, time to weigh his options and give the team time to decide what kind of roster they can build around the big man.
The Celtics have just one pick in the June 27th draft, No. 16 overall. "We're always having discussions about moving up and down and moving out," said Ainge. "That's just like every other year. But I don't know what the chances are of that happening."
So will Garnett return for next year? For the point Garnett is at in his career, starting over in a different team would be difficult. It's likely he'll return for one more season, but that is also dependent on Paul Pierce and Doc Rivers returning as well. Garnett has two years and over $24 million left on his contract, with $6 million guaranteed in his final year.
Garnett played all six games in the Celtics' first-round series against the New York Knicks. He averaged 12.7 points and 13..7 rebounds in 35.3 minutes per game. The Celtics lost in six to the Knicks.
References: Boston Herald and SB Nation.
If you are a basketball player and have a foot problem, call our Newington, Kensington, or Middletown office to make an appointment.
Craig M. Kaufman, DPM
Connecticut Foot Care Centers
Sports Medicine Podiatrist in CT
Podiatrist in Newington
Visit our website, like our page on Facebook, and follow our tweets on Twitter

No comments:

Post a Comment